Baird lowered the firm’s price target on Thermo Fisher (TMO) to $573 from $603 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results where the company lowered its 2025 revenue and earnings guidance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher’s Resilience and Strategic Positioning Justify Buy Rating Despite Macroeconomic Challenges
- Thermo Fisher Scientific Reports Strong Q1 2025 Results
- Thermo Fisher Scientific Navigates Strong Q1 Amid Challenges
- Thermo Fisher price target lowered to $610 from $670 at Goldman Sachs
- Thermo Fisher price target lowered to $600 from $625 at Leerink